Global Gene Editing Therapy Market Growth (Status and Outlook) 2026-2032
The global Gene Editing Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Gene Editing Therapy players cover CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Gene Editing Therapy Industry Forecast? looks at past sales and reviews total world Gene Editing Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene Editing Therapy sales for 2026 through 2032. With Gene Editing Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Editing Therapy industry.
This Insight Report provides a comprehensive analysis of the global Gene Editing Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Editing Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Gene Editing Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Editing Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Editing Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Gene Editing Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Gene Editing Therapy players cover CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Gene Editing Therapy Industry Forecast? looks at past sales and reviews total world Gene Editing Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene Editing Therapy sales for 2026 through 2032. With Gene Editing Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Editing Therapy industry.
This Insight Report provides a comprehensive analysis of the global Gene Editing Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Editing Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Gene Editing Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Editing Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Editing Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Editing Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- In Vivo Gene Editing
- In Vitro Gene Editing
- Thalassemia
- Cancer
- Cystic Fibrosis
- Muscular Dystrophy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CRISPR Therapeutics
- Beam Therapeutics
- Editas Medicine
- Verve Therapeutics
- Bluebird Bio
- Intellia Therapeutics
- Vertex Pharmaceuticals
- Caribou Biosciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Editing Therapy Market Size (2021-2032)
2.1.2 Gene Editing Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene Editing Therapy by Country/Region (2021, 2025 & 2032)
2.2 Gene Editing Therapy Segment by Type
2.2.1 In Vivo Gene Editing
2.2.2 In Vitro Gene Editing
2.2.3 Gene Editing Therapy Market Size by Type
2.2.3.1 Gene Editing Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene Editing Therapy Market Size Market Share by Type (2021-2026)
2.3 Gene Editing Therapy Segment by Application
2.3.1 Thalassemia
2.3.2 Cancer
2.3.3 Cystic Fibrosis
2.3.4 Muscular Dystrophy
2.3.5 Others
2.3.6 Gene Editing Therapy Market Size by Application
2.3.6.1 Gene Editing Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Gene Editing Therapy Market Size Market Share by Application (2021-2026)
3 GENE EDITING THERAPY MARKET SIZE BY PLAYER
3.1 Gene Editing Therapy Market Size Market Share by Player
3.1.1 Global Gene Editing Therapy Revenue by Player (2021-2026)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Gene Editing Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE EDITING THERAPY BY REGION
4.1 Gene Editing Therapy Market Size by Region (2021-2026)
4.2 Global Gene Editing Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene Editing Therapy Market Size Growth (2021-2026)
4.4 APAC Gene Editing Therapy Market Size Growth (2021-2026)
4.5 Europe Gene Editing Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene Editing Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene Editing Therapy Market Size by Country (2021-2026)
5.2 Americas Gene Editing Therapy Market Size by Type (2021-2026)
5.3 Americas Gene Editing Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Editing Therapy Market Size by Region (2021-2026)
6.2 APAC Gene Editing Therapy Market Size by Type (2021-2026)
6.3 APAC Gene Editing Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Editing Therapy Market Size by Country (2021-2026)
7.2 Europe Gene Editing Therapy Market Size by Type (2021-2026)
7.3 Europe Gene Editing Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Editing Therapy by Region (2021-2026)
8.2 Middle East & Africa Gene Editing Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene Editing Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE EDITING THERAPY MARKET FORECAST
10.1 Global Gene Editing Therapy Forecast by Region (2027-2032)
10.1.1 Global Gene Editing Therapy Forecast by Region (2027-2032)
10.1.2 Americas Gene Editing Therapy Forecast
10.1.3 APAC Gene Editing Therapy Forecast
10.1.4 Europe Gene Editing Therapy Forecast
10.1.5 Middle East & Africa Gene Editing Therapy Forecast
10.2 Americas Gene Editing Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Gene Editing Therapy Forecast
10.2.2 Canada Market Gene Editing Therapy Forecast
10.2.3 Mexico Market Gene Editing Therapy Forecast
10.2.4 Brazil Market Gene Editing Therapy Forecast
10.3 APAC Gene Editing Therapy Forecast by Region (2027-2032)
10.3.1 China Gene Editing Therapy Market Forecast
10.3.2 Japan Market Gene Editing Therapy Forecast
10.3.3 Korea Market Gene Editing Therapy Forecast
10.3.4 Southeast Asia Market Gene Editing Therapy Forecast
10.3.5 India Market Gene Editing Therapy Forecast
10.3.6 Australia Market Gene Editing Therapy Forecast
10.4 Europe Gene Editing Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Gene Editing Therapy Forecast
10.4.2 France Market Gene Editing Therapy Forecast
10.4.3 UK Market Gene Editing Therapy Forecast
10.4.4 Italy Market Gene Editing Therapy Forecast
10.4.5 Russia Market Gene Editing Therapy Forecast
10.5 Middle East & Africa Gene Editing Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene Editing Therapy Forecast
10.5.2 South Africa Market Gene Editing Therapy Forecast
10.5.3 Israel Market Gene Editing Therapy Forecast
10.5.4 Turkey Market Gene Editing Therapy Forecast
10.6 Global Gene Editing Therapy Forecast by Type (2027-2032)
10.7 Global Gene Editing Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene Editing Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Information
11.1.2 CRISPR Therapeutics Gene Editing Therapy Product Offered
11.1.3 CRISPR Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CRISPR Therapeutics Main Business Overview
11.1.5 CRISPR Therapeutics Latest Developments
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Information
11.2.2 Beam Therapeutics Gene Editing Therapy Product Offered
11.2.3 Beam Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Beam Therapeutics Main Business Overview
11.2.5 Beam Therapeutics Latest Developments
11.3 Editas Medicine
11.3.1 Editas Medicine Company Information
11.3.2 Editas Medicine Gene Editing Therapy Product Offered
11.3.3 Editas Medicine Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Editas Medicine Main Business Overview
11.3.5 Editas Medicine Latest Developments
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Information
11.4.2 Verve Therapeutics Gene Editing Therapy Product Offered
11.4.3 Verve Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Verve Therapeutics Main Business Overview
11.4.5 Verve Therapeutics Latest Developments
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Information
11.5.2 Bluebird Bio Gene Editing Therapy Product Offered
11.5.3 Bluebird Bio Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bluebird Bio Main Business Overview
11.5.5 Bluebird Bio Latest Developments
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Information
11.6.2 Intellia Therapeutics Gene Editing Therapy Product Offered
11.6.3 Intellia Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Intellia Therapeutics Main Business Overview
11.6.5 Intellia Therapeutics Latest Developments
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Information
11.7.2 Vertex Pharmaceuticals Gene Editing Therapy Product Offered
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Vertex Pharmaceuticals Main Business Overview
11.7.5 Vertex Pharmaceuticals Latest Developments
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Information
11.8.2 Caribou Biosciences Gene Editing Therapy Product Offered
11.8.3 Caribou Biosciences Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Caribou Biosciences Main Business Overview
11.8.5 Caribou Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Editing Therapy Market Size (2021-2032)
2.1.2 Gene Editing Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene Editing Therapy by Country/Region (2021, 2025 & 2032)
2.2 Gene Editing Therapy Segment by Type
2.2.1 In Vivo Gene Editing
2.2.2 In Vitro Gene Editing
2.2.3 Gene Editing Therapy Market Size by Type
2.2.3.1 Gene Editing Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene Editing Therapy Market Size Market Share by Type (2021-2026)
2.3 Gene Editing Therapy Segment by Application
2.3.1 Thalassemia
2.3.2 Cancer
2.3.3 Cystic Fibrosis
2.3.4 Muscular Dystrophy
2.3.5 Others
2.3.6 Gene Editing Therapy Market Size by Application
2.3.6.1 Gene Editing Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Gene Editing Therapy Market Size Market Share by Application (2021-2026)
3 GENE EDITING THERAPY MARKET SIZE BY PLAYER
3.1 Gene Editing Therapy Market Size Market Share by Player
3.1.1 Global Gene Editing Therapy Revenue by Player (2021-2026)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Gene Editing Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE EDITING THERAPY BY REGION
4.1 Gene Editing Therapy Market Size by Region (2021-2026)
4.2 Global Gene Editing Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene Editing Therapy Market Size Growth (2021-2026)
4.4 APAC Gene Editing Therapy Market Size Growth (2021-2026)
4.5 Europe Gene Editing Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene Editing Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene Editing Therapy Market Size by Country (2021-2026)
5.2 Americas Gene Editing Therapy Market Size by Type (2021-2026)
5.3 Americas Gene Editing Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Editing Therapy Market Size by Region (2021-2026)
6.2 APAC Gene Editing Therapy Market Size by Type (2021-2026)
6.3 APAC Gene Editing Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Editing Therapy Market Size by Country (2021-2026)
7.2 Europe Gene Editing Therapy Market Size by Type (2021-2026)
7.3 Europe Gene Editing Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Editing Therapy by Region (2021-2026)
8.2 Middle East & Africa Gene Editing Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene Editing Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE EDITING THERAPY MARKET FORECAST
10.1 Global Gene Editing Therapy Forecast by Region (2027-2032)
10.1.1 Global Gene Editing Therapy Forecast by Region (2027-2032)
10.1.2 Americas Gene Editing Therapy Forecast
10.1.3 APAC Gene Editing Therapy Forecast
10.1.4 Europe Gene Editing Therapy Forecast
10.1.5 Middle East & Africa Gene Editing Therapy Forecast
10.2 Americas Gene Editing Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Gene Editing Therapy Forecast
10.2.2 Canada Market Gene Editing Therapy Forecast
10.2.3 Mexico Market Gene Editing Therapy Forecast
10.2.4 Brazil Market Gene Editing Therapy Forecast
10.3 APAC Gene Editing Therapy Forecast by Region (2027-2032)
10.3.1 China Gene Editing Therapy Market Forecast
10.3.2 Japan Market Gene Editing Therapy Forecast
10.3.3 Korea Market Gene Editing Therapy Forecast
10.3.4 Southeast Asia Market Gene Editing Therapy Forecast
10.3.5 India Market Gene Editing Therapy Forecast
10.3.6 Australia Market Gene Editing Therapy Forecast
10.4 Europe Gene Editing Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Gene Editing Therapy Forecast
10.4.2 France Market Gene Editing Therapy Forecast
10.4.3 UK Market Gene Editing Therapy Forecast
10.4.4 Italy Market Gene Editing Therapy Forecast
10.4.5 Russia Market Gene Editing Therapy Forecast
10.5 Middle East & Africa Gene Editing Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene Editing Therapy Forecast
10.5.2 South Africa Market Gene Editing Therapy Forecast
10.5.3 Israel Market Gene Editing Therapy Forecast
10.5.4 Turkey Market Gene Editing Therapy Forecast
10.6 Global Gene Editing Therapy Forecast by Type (2027-2032)
10.7 Global Gene Editing Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene Editing Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Information
11.1.2 CRISPR Therapeutics Gene Editing Therapy Product Offered
11.1.3 CRISPR Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CRISPR Therapeutics Main Business Overview
11.1.5 CRISPR Therapeutics Latest Developments
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Information
11.2.2 Beam Therapeutics Gene Editing Therapy Product Offered
11.2.3 Beam Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Beam Therapeutics Main Business Overview
11.2.5 Beam Therapeutics Latest Developments
11.3 Editas Medicine
11.3.1 Editas Medicine Company Information
11.3.2 Editas Medicine Gene Editing Therapy Product Offered
11.3.3 Editas Medicine Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Editas Medicine Main Business Overview
11.3.5 Editas Medicine Latest Developments
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Information
11.4.2 Verve Therapeutics Gene Editing Therapy Product Offered
11.4.3 Verve Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Verve Therapeutics Main Business Overview
11.4.5 Verve Therapeutics Latest Developments
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Information
11.5.2 Bluebird Bio Gene Editing Therapy Product Offered
11.5.3 Bluebird Bio Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bluebird Bio Main Business Overview
11.5.5 Bluebird Bio Latest Developments
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Information
11.6.2 Intellia Therapeutics Gene Editing Therapy Product Offered
11.6.3 Intellia Therapeutics Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Intellia Therapeutics Main Business Overview
11.6.5 Intellia Therapeutics Latest Developments
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Information
11.7.2 Vertex Pharmaceuticals Gene Editing Therapy Product Offered
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Vertex Pharmaceuticals Main Business Overview
11.7.5 Vertex Pharmaceuticals Latest Developments
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Information
11.8.2 Caribou Biosciences Gene Editing Therapy Product Offered
11.8.3 Caribou Biosciences Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Caribou Biosciences Main Business Overview
11.8.5 Caribou Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Editing Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene Editing Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of In Vivo Gene Editing
Table 4. Major Players of In Vitro Gene Editing
Table 5. Gene Editing Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Table 8. Gene Editing Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Gene Editing Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene Editing Therapy Revenue Market Share by Player (2021-2026)
Table 13. Gene Editing Therapy Key Players Head office and Products Offered
Table 14. Gene Editing Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Gene Editing Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene Editing Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene Editing Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene Editing Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene Editing Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene Editing Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Editing Therapy
Table 39. Key Market Challenges & Risks of Gene Editing Therapy
Table 40. Key Industry Trends of Gene Editing Therapy
Table 41. Global Gene Editing Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene Editing Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene Editing Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene Editing Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. CRISPR Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 46. CRISPR Therapeutics Gene Editing Therapy Product Offered
Table 47. CRISPR Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. CRISPR Therapeutics Main Business
Table 49. CRISPR Therapeutics Latest Developments
Table 50. Beam Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 51. Beam Therapeutics Gene Editing Therapy Product Offered
Table 52. Beam Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Beam Therapeutics Main Business
Table 54. Beam Therapeutics Latest Developments
Table 55. Editas Medicine Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 56. Editas Medicine Gene Editing Therapy Product Offered
Table 57. Editas Medicine Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Editas Medicine Main Business
Table 59. Editas Medicine Latest Developments
Table 60. Verve Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 61. Verve Therapeutics Gene Editing Therapy Product Offered
Table 62. Verve Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Verve Therapeutics Main Business
Table 64. Verve Therapeutics Latest Developments
Table 65. Bluebird Bio Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 66. Bluebird Bio Gene Editing Therapy Product Offered
Table 67. Bluebird Bio Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Bluebird Bio Main Business
Table 69. Bluebird Bio Latest Developments
Table 70. Intellia Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 71. Intellia Therapeutics Gene Editing Therapy Product Offered
Table 72. Intellia Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Intellia Therapeutics Main Business
Table 74. Intellia Therapeutics Latest Developments
Table 75. Vertex Pharmaceuticals Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 76. Vertex Pharmaceuticals Gene Editing Therapy Product Offered
Table 77. Vertex Pharmaceuticals Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Vertex Pharmaceuticals Main Business
Table 79. Vertex Pharmaceuticals Latest Developments
Table 80. Caribou Biosciences Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 81. Caribou Biosciences Gene Editing Therapy Product Offered
Table 82. Caribou Biosciences Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Caribou Biosciences Main Business
Table 84. Caribou Biosciences Latest Developments
Table 1. Gene Editing Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene Editing Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of In Vivo Gene Editing
Table 4. Major Players of In Vitro Gene Editing
Table 5. Gene Editing Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Table 8. Gene Editing Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Gene Editing Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene Editing Therapy Revenue Market Share by Player (2021-2026)
Table 13. Gene Editing Therapy Key Players Head office and Products Offered
Table 14. Gene Editing Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Gene Editing Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene Editing Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene Editing Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene Editing Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene Editing Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene Editing Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene Editing Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene Editing Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene Editing Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Editing Therapy
Table 39. Key Market Challenges & Risks of Gene Editing Therapy
Table 40. Key Industry Trends of Gene Editing Therapy
Table 41. Global Gene Editing Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene Editing Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene Editing Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene Editing Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. CRISPR Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 46. CRISPR Therapeutics Gene Editing Therapy Product Offered
Table 47. CRISPR Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. CRISPR Therapeutics Main Business
Table 49. CRISPR Therapeutics Latest Developments
Table 50. Beam Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 51. Beam Therapeutics Gene Editing Therapy Product Offered
Table 52. Beam Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Beam Therapeutics Main Business
Table 54. Beam Therapeutics Latest Developments
Table 55. Editas Medicine Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 56. Editas Medicine Gene Editing Therapy Product Offered
Table 57. Editas Medicine Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Editas Medicine Main Business
Table 59. Editas Medicine Latest Developments
Table 60. Verve Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 61. Verve Therapeutics Gene Editing Therapy Product Offered
Table 62. Verve Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Verve Therapeutics Main Business
Table 64. Verve Therapeutics Latest Developments
Table 65. Bluebird Bio Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 66. Bluebird Bio Gene Editing Therapy Product Offered
Table 67. Bluebird Bio Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Bluebird Bio Main Business
Table 69. Bluebird Bio Latest Developments
Table 70. Intellia Therapeutics Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 71. Intellia Therapeutics Gene Editing Therapy Product Offered
Table 72. Intellia Therapeutics Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Intellia Therapeutics Main Business
Table 74. Intellia Therapeutics Latest Developments
Table 75. Vertex Pharmaceuticals Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 76. Vertex Pharmaceuticals Gene Editing Therapy Product Offered
Table 77. Vertex Pharmaceuticals Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Vertex Pharmaceuticals Main Business
Table 79. Vertex Pharmaceuticals Latest Developments
Table 80. Caribou Biosciences Details, Company Type, Gene Editing Therapy Area Served and Its Competitors
Table 81. Caribou Biosciences Gene Editing Therapy Product Offered
Table 82. Caribou Biosciences Gene Editing Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Caribou Biosciences Main Business
Table 84. Caribou Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Gene Editing Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Editing Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene Editing Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene Editing Therapy Sales Market Share by Country/Region (2025)
Figure 8. Gene Editing Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene Editing Therapy Market Size Market Share by Type in 2025
Figure 10. Gene Editing Therapy in Thalassemia
Figure 11. Global Gene Editing Therapy Market: Thalassemia (2021-2026) & ($ millions)
Figure 12. Gene Editing Therapy in Cancer
Figure 13. Global Gene Editing Therapy Market: Cancer (2021-2026) & ($ millions)
Figure 14. Gene Editing Therapy in Cystic Fibrosis
Figure 15. Global Gene Editing Therapy Market: Cystic Fibrosis (2021-2026) & ($ millions)
Figure 16. Gene Editing Therapy in Muscular Dystrophy
Figure 17. Global Gene Editing Therapy Market: Muscular Dystrophy (2021-2026) & ($ millions)
Figure 18. Gene Editing Therapy in Others
Figure 19. Global Gene Editing Therapy Market: Others (2021-2026) & ($ millions)
Figure 20. Global Gene Editing Therapy Market Size Market Share by Application in 2025
Figure 21. Global Gene Editing Therapy Revenue Market Share by Player in 2025
Figure 22. Global Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Figure 23. Americas Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 24. APAC Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 25. Europe Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 27. Americas Gene Editing Therapy Value Market Share by Country in 2025
Figure 28. United States Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Gene Editing Therapy Market Size Market Share by Region in 2025
Figure 33. APAC Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 34. APAC Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 35. China Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. India Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Gene Editing Therapy Market Size Market Share by Country in 2025
Figure 42. Europe Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 43. Europe Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 44. Germany Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. France Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 58. APAC Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 59. Europe Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 61. United States Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 62. Canada Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 63. Mexico Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 64. Brazil Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 65. China Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 66. Japan Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 67. Korea Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 69. India Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 70. Australia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 71. Germany Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 72. France Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 73. UK Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 74. Italy Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 75. Russia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 76. Egypt Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 77. South Africa Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 78. Israel Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 79. Turkey Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 80. Global Gene Editing Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Gene Editing Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 1. Gene Editing Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Editing Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene Editing Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene Editing Therapy Sales Market Share by Country/Region (2025)
Figure 8. Gene Editing Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene Editing Therapy Market Size Market Share by Type in 2025
Figure 10. Gene Editing Therapy in Thalassemia
Figure 11. Global Gene Editing Therapy Market: Thalassemia (2021-2026) & ($ millions)
Figure 12. Gene Editing Therapy in Cancer
Figure 13. Global Gene Editing Therapy Market: Cancer (2021-2026) & ($ millions)
Figure 14. Gene Editing Therapy in Cystic Fibrosis
Figure 15. Global Gene Editing Therapy Market: Cystic Fibrosis (2021-2026) & ($ millions)
Figure 16. Gene Editing Therapy in Muscular Dystrophy
Figure 17. Global Gene Editing Therapy Market: Muscular Dystrophy (2021-2026) & ($ millions)
Figure 18. Gene Editing Therapy in Others
Figure 19. Global Gene Editing Therapy Market: Others (2021-2026) & ($ millions)
Figure 20. Global Gene Editing Therapy Market Size Market Share by Application in 2025
Figure 21. Global Gene Editing Therapy Revenue Market Share by Player in 2025
Figure 22. Global Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Figure 23. Americas Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 24. APAC Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 25. Europe Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Gene Editing Therapy Market Size 2021-2026 ($ millions)
Figure 27. Americas Gene Editing Therapy Value Market Share by Country in 2025
Figure 28. United States Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Gene Editing Therapy Market Size Market Share by Region in 2025
Figure 33. APAC Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 34. APAC Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 35. China Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. India Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Gene Editing Therapy Market Size Market Share by Country in 2025
Figure 42. Europe Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 43. Europe Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 44. Germany Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. France Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Gene Editing Therapy Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Gene Editing Therapy Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Gene Editing Therapy Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Gene Editing Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 58. APAC Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 59. Europe Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 61. United States Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 62. Canada Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 63. Mexico Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 64. Brazil Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 65. China Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 66. Japan Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 67. Korea Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 69. India Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 70. Australia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 71. Germany Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 72. France Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 73. UK Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 74. Italy Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 75. Russia Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 76. Egypt Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 77. South Africa Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 78. Israel Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 79. Turkey Gene Editing Therapy Market Size 2027-2032 ($ millions)
Figure 80. Global Gene Editing Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Gene Editing Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Gene Editing Therapy Market Size 2027-2032 ($ millions)
